Jonathan Schwartz

Insider Reports History

Entity
Individual
Location
430 East 29 Th Street, Suite 1040, New York, NY
Signature
/s/ Martin Wilson, as attorney-in-fact for Jonathan Schwartz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Schwartz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Chief Medical & Gene Therapy Officer Exhibit 24: Power of Attorney Common Stock 172K $4.9M $28.43 Mar 25, 2024 Direct
Tabula Rasa HealthCare, Inc. Director Common Stock 0 $10.50 Nov 3, 2023 Direct

Insider Reports Filed by Jonathan Schwartz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Mar 25, 2024 0 $0 3 Apr 3, 2024 Chief Medical & Gene Therapy Officer Exhibit 24: Power of Attorney
TRHC Tabula Rasa HealthCare, Inc. Nov 3, 2023 2 $0 4 Nov 14, 2023 Director
TRHC Tabula Rasa HealthCare, Inc. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
RCKT ROCKET PHARMACEUTICALS, INC. Feb 17, 2023 1 -$67.8K 4 Feb 22, 2023 Chief Medical Officer & Clinical Development, SVP
RCKT ROCKET PHARMACEUTICALS, INC. Feb 14, 2023 4 $0 4/A Feb 22, 2023 Chief Medical Officer & Clinical Development, SVP
TRHC Tabula Rasa HealthCare, Inc. Sep 13, 2022 1 $0 4 Sep 15, 2022 Director
TRHC Tabula Rasa HealthCare, Inc. Sep 13, 2022 0 $0 3 Sep 15, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Aug 12, 2022 1 $0 4 Aug 16, 2022 Chief Medical Officer & Clinical Development, SVP
RCKT ROCKET PHARMACEUTICALS, INC. Mar 30, 2022 6 -$2.19M 4/A Apr 4, 2022 Chief Medical Officer & Clinical Development, SVP.
RCKT ROCKET PHARMACEUTICALS, INC. Feb 14, 2022 2 $0 4 Feb 16, 2022 Chief Medical Officer & Clinical Development, SVP. Exhibit 24: Power of Attorney